We aim to provide the proof of concept for a novel generic tool to facilitate structural studies of chemokinereceptors. The proposed technology has the potential to revolutionize structural studies of chemokine receptorswhich are therapeutic targets for the pharmaceutical industry.
|Effective start/end date
|1/03/20 → 28/02/22
- FNR - Fonds National de la Recherche: €374,500.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.